UBS Group
TNYA icon

UBS Group’s Tenaya Therapeutics TNYA Stock Holding History

UBS Group’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$337K Sell
456,555
-208,625
-31% -$158K ﹤0.01% 6472
2026
Q1 		$460K Buy
665,180
+85,579
+15% +$63.2K ﹤0.01% 6140
2025
Q4 		$413K Buy
579,601
+382,874
+195% +$521K ﹤0.01% 6194
2025
Q3 		$319K Buy
196,727
+76,551
+64% +$77.1K ﹤0.01% 6395
2025
Q2 		$73.4K Sell
120,176
-134,568
-53% -$68.5K ﹤0.01% 7476
2025
Q1 		$145K Sell
254,744
-223,764
-47% -$221K ﹤0.01% 6767
2024
Q4 		$684K Buy
478,508
+452,370
+1,731% +$1.01M ﹤0.01% 5625
2024
Q3 		$50.4K Buy
26,138
+9,293
+55% +$26.2K ﹤0.01% 6815
2024
Q2 		$52.2K Sell
16,845
-93,331
-85% -$385K ﹤0.01% 6655
2024
Q1 		$576K Buy
110,176
+65,162
+145% +$312K ﹤0.01% 5091
2023
Q4 		$146K Buy
45,014
+19,530
+77% +$42.2K ﹤0.01% 5964
2023
Q3 		$65K Sell
25,484
-837
-3% -$3.5K ﹤0.01% 6121
2023
Q2 		$155K Buy
26,321
+11,592
+79% +$67.4K ﹤0.01% 5659
2023
Q1 		$42K Buy
14,729
+2,669
+22% +$7.5K ﹤0.01% 6576
2022
Q4 		$24.2K Buy
+12,060
New +$29.4K ﹤0.01% 7455
2022
Q3 		– Sell
-261
Closed -$1K – 10931
2022
Q2 		$1K Sell
261
-106
-29% -$858 ﹤0.01% 9967
2022
Q1 		$4K Sell
367
-2,923
-89% -$35.4K ﹤0.01% 9323
2021
Q4 		$62K Buy
3,290
+2,915
+777% +$63.5K ﹤0.01% 6728
2021
Q3 		$8K Buy
+375
New +$8.06K ﹤0.01% 8228

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group's TNYA Position: Q2 2026 in Review

UBS Group reduced its Tenaya Therapeutics (TNYA) stake by 31% in Q2 2026, selling an estimated $158K and leaving 456,555 shares worth $337K. The position accounts for ﹤0.01% of the portfolio, ranked #6472.

UBS Group first reported a position in TNYA in Q3 2021 and has held it in 19 quarters since. The position peaked at $684K in Q4 2024. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • UBS Group held 456,555 shares of Tenaya Therapeutics worth $337K as of Q2 2026.
  • UBS Group sold 208,625 Tenaya Therapeutics shares in Q2 2026, an estimated $158K.
  • Tenaya Therapeutics made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #6472 holding.
  • UBS Group first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • UBS Group's Tenaya Therapeutics position peaked at $684K in Q4 2024.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.